Pfizer Ltd.
| BSE: 500680 | Sector: Health care |
| NSE: PFIZER | ISIN Code: INE182A01018 |
| BSE 00:00 | 17 May | 5215.25 |
-63.70 (-1.21%) |
OPEN
5343.00 |
HIGH
5343.00 |
LOW
5180.00 |
| NSE 00:00 | 17 May | 5217.85 |
-58.05 (-1.10%) |
OPEN
5329.00 |
HIGH
5347.75 |
LOW
5176.20 |
| OPEN | 5343.00 |
| PREVIOUS CLOSE | 5278.95 |
| VOLUME | 8295 |
| 52-Week high | 5875.00 |
| 52-Week low | 3940.00 |
| P/E | 47.71 |
| Mkt Cap.(Rs cr) | 23,860 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Pfizer Ltd. (PFIZER) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 1002.10 | -4.50 | -0.45 | 13266.48 |
| Cipla | 881.05 | -23.05 | -2.55 | 12659.15 |
| Sun Pharma.Inds. | 686.95 | -4.15 | -0.60 | 12531.93 |
| Dr Reddy's Labs | 5251.25 | 55.40 | 1.07 | 11850.40 |
| Lupin | 1188.95 | 10.15 | 0.86 | 11025.66 |
| Apollo Hospitals | 3151.05 | 11.40 | 0.36 | 9794.50 |
| Glenmark Pharma. | 604.15 | -3.70 | -0.61 | 6712.63 |
| Alkem Lab | 2981.20 | -13.85 | -0.46 | 6677.08 |
| Cadila Health. | 611.60 | -5.50 | -0.89 | 6347.40 |
| Torrent Pharma. | 2764.75 | 42.25 | 1.55 | 6168.44 |
| Divi's Lab. | 4043.20 | 21.20 | 0.53 | 5310.57 |
| Ipca Labs. | 2178.95 | 30.60 | 1.42 | 4337.82 |
| Piramal Enterp. | 1653.05 | 20.05 | 1.23 | 4219.19 |
| Alembic Pharma | 942.90 | 4.35 | 0.46 | 4132.55 |
| Abbott India | 16224.75 | 126.45 | 0.79 | 4093.14 |
| Glaxosmi. Pharma | 1518.15 | 14.35 | 0.95 | 3224.68 |
| Jubilant Pharmo | 830.65 | 7.75 | 0.94 | 3139.90 |
| Sanofi India | 7720.80 | -26.75 | -0.35 | 2901.90 |
| Laurus Labs | 472.75 | 4.50 | 0.96 | 2797.34 |
| Gland Pharma | 2792.85 | -89.25 | -3.10 | 2633.24 |
Quick Links for Pfizer:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
